This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Looking for ways to monetize skills quickly? Turn your talents into cash and start earning today with these strategies.
17,417 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Fluence Energy surged nearly 100% in a week on big contract wins and a growing backlog. A quartet of AI-exposed energ...
Fox stock is down after announcing a Roku deal, leaving investors weighing value vs risk. This guide breaks down the ...
Palantir surging in July shines a contrast with Google’s cloud-driven growth. Both giants report strong quarters, but...
In 2025, rare earths drew intense attention as prices and equities raced higher. The rally cooled quickly, leaving in...
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...
SoundHound AI stock has slipped in 2026, leaving investors to weigh risk against opportunity. This guide breaks down ...
As clean energy climbs, storage plays a pivotal role. This article breaks down why energy stock soaring today points ...
The first half of the year brought a sharp move for ServiceNow as AI expectations collided with reality. This article...
On Feb 26, The Trade Desk faced a sharp move as management guided softer revenue growth and rising margins strained b...
Oracle is sitting on a massive backlog that could redefine its AI trajectory in 2026. This deep dive breaks down what...
Fantasy Top captivated Crypto Twitter with a fresh take on fantasy sports powered by blockchain. Now, after two years...